Nov. 3: Therapeutic Vaccines: Steady Wins the Race
	Recent news of modest success with a preventive HIV vaccine has led some to wonder whether we’ve moved any closer to a compound that can train the immune system to better control the virus—a therapeutic vaccine. AIDSmeds talked to two HIV vaccine experts to find out where we are now and where we’re going.

	Oct. 13: HIV Eradication: One Step Closer
	Hopes for HIV eradication have been stymied by the current crop of antiretroviral drugs’ inability to get at the reservoir of inactive HIV-infected CD4 cells that hide in the body. Now, Robert Siliciano, MD, PhD, from Johns Hopkins University says not only that it’s possible to get at these cells, but that his lab is already on track to identifying drugs that can wake up these cells. The discovery represents a significant step on the path to ultimately curing HIV.

	Sep. 22: HCV: Wait for Something New or Treat Now?
	Some people coinfected with both HIV and hepatitis C virus (HCV) are holding out for new treatments that will improve their chances of permanently clearing HCV. David Evans talks with HCV/HIV coinfection activist Tracy Swan to find out whether the current crop of experimental agents will be worth the wait.